Recommendations for the transfusion of red blood cells.
暂无分享,去创建一个
[1] G. Guyatt,et al. Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[2] J. Loscalzo,et al. Anemia‐induced increase in the bleeding time:implications for treatment of nonsurgical blood loss , 2001, Transfusion.
[3] P. Hebert,et al. Review of published recommendations and guidelines for the transfusion of allogeneic red blood cells and plasma. , 1997 .
[4] J. Wood,et al. Guidelines for implementation of a maximum surgical blood order schedule. The British Committee for Standards in Haematology Blood Transfusion Task Force. , 2008, Clinical and laboratory haematology.
[5] C. Pegelow,et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. , 1995, The New England journal of medicine.
[6] P. Davies,et al. A new formula for blood transfusion volume in the critically ill , 2005, Archives of Disease in Childhood.
[7] R. Martineau,et al. A Pilot Trial Evaluating the Clinical Effects of Prolonged Storage of Red Cells , 2005, Anesthesia and analgesia.
[8] C. Rodeck,et al. Transfusion guidelines for neonates and older children , 2004, British journal of haematology.
[9] V. Lawrence,et al. Perioperative blood transfusion and postoperative mortality. , 1998, JAMA.
[10] Christopher G Ellis,et al. The microcirculation as a functional system , 2005, Critical care.
[11] N. Olivieri. The beta-thalassemias. , 1999, The New England journal of medicine.
[12] Joon-Oh Park,et al. Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer , 2005, Cancer Chemotherapy and Pharmacology.
[13] M. Osaki,et al. Expression of erythropoietin receptor in human Merkel cell carcinoma of the eyelid. , 2006, Anticancer research.
[14] A. Laupacis,et al. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. , 1998, The British journal of surgery.
[15] C. Ince,et al. Assessment of regional tissue oxygenation , 1999, Intensive Care Medicine.
[16] H. Krumholz,et al. Blood transfusion in elderly patients with acute myocardial infarction. , 2001, The New England journal of medicine.
[17] P. Davies,et al. Calculating the required transfusion volume in children , 2007, Transfusion.
[18] Chris A Rogers,et al. Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.
[19] R. Reiling. Perioperative red cell transfusion. , 1990, Ohio medicine : journal of the Ohio State Medical Association.
[20] Scott T. Miller,et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.
[21] P. Van der Linden,et al. Physiologic aspects of anemia. , 2004, Critical care clinics.
[22] M. Dicato. Anemia in cancer: some pathophysiological aspects. , 2003, The oncologist.
[23] P. Dendy,et al. Guidelines on gamma irradiation of blood components for the prevention of transfusion‐associated graft‐versus‐host disease , 1996, Transfusion medicine.
[24] R. C. Dennis,et al. Limitations of the hematocrit level to assess the need for red blood cell transfusion in hypovolemic anemic patients , 2006, Transfusion.
[25] N. Heddle,et al. Biologic effects of leukocytes present in transfused cellular blood products. , 1994, Blood.
[26] W. Pevec,et al. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. , 1997, American journal of surgery.
[27] R. Califf,et al. International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. , 2008, The American journal of cardiology.
[28] C. Borchgrevink,et al. The Role of Red Cells in Haemostasis: the Relation between Haematocrit, Bleeding Time and Platelet Adhesiveness , 1961, British journal of haematology.
[29] J. Marshall,et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? , 2001, Critical care medicine.
[30] S. Hill,et al. Transfusion triggers: a systematic review of the literature. , 2002, Transfusion medicine reviews.
[31] P. Rebulla,et al. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. , 2006, Haematologica.
[32] J. Silber,et al. A modified transfusion program for prevention of stroke in sickle cell disease. , 1992, Blood.
[33] N. Roubinian,et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2016, The Cochrane database of systematic reviews.
[34] M. Telen. Principles and problems of transfusion in sickle cell disease. , 2001, Seminars in hematology.
[35] L. Sprague,et al. Split Course Hyperfractionated Accelerated Radio-Chemotherapy (SCHARC) for patients with advanced head and neck cancer: Influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis , 2006, BMC Cancer.
[36] T. Ratko,et al. Evidence‐based recommendations for the use of WBC‐reduced cellular blood components , 2001, Transfusion.
[37] J. Wallis,et al. Nitric oxide and blood: a review , 2005, Transfusion medicine.
[38] R. Califf,et al. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.
[39] J. Marshall,et al. Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study , 1999, Critical care.
[40] R. Adams,et al. Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial , 2001, Transfusion.
[41] P. Tiberghien,et al. Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice.Société Française de Greffe de Moelle. , 2000, Bone marrow transplantation.
[42] R. Rodgers,et al. Bleeding time: a guide to its diagnostic and clinical utility. , 1990, Archives of pathology & laboratory medicine.
[43] K. Blackwell,et al. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? , 2004, The oncologist.
[44] G. Remuzzi,et al. URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS , 1982, The Lancet.
[45] C. Manno,et al. Guidelines for assessing appropriateness of pediatric transfusion , 2002, Transfusion.
[46] M. Stevenson,et al. Anemia, tumor hypoxemia, and the cancer patient. , 2005, International journal of radiation oncology, biology, physics.
[47] V. Cocquyt,et al. Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. , 2003, Critical reviews in oncology/hematology.
[48] C. Wardrop,et al. Consensus on red cell transfusion , 1995, BMJ.
[49] S. Miller,et al. Effect of transfusion in acute chest syndrome of sickle cell disease. , 1995, The Journal of pediatrics.
[50] R. Storb,et al. Transfusion problems associated with transplantation. , 1981, Seminars in hematology.
[51] J. Duguid,et al. Guidelines for the clinical use of red cell transfusions , 2001, British journal of haematology.
[52] Scott T. Miller,et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. , 1995, The Journal of pediatrics.
[53] J. Carson,et al. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion , 2002, Transfusion.
[54] Kaaron Benson,et al. Guide to the Preparation, Use and Quality Assurance of Blood Components , 1999 .
[55] C. Ho. The hemostatic effect of adequate red cell transfusion in patients with anemia and thrombocytopenia , 1996, Transfusion.
[56] J. Hess,et al. Buffering and dilution in red blood cell storage , 2006, Transfusion.
[57] B. Larke,et al. Guidelines for red blood cell and plasma transfusion for adults and children. , 1997, The International journal of risk & safety in medicine.
[58] C. Forbes,et al. Contribution of the haematocrit to the bleeding time. , 1983, Haemostasis.
[59] R. Weiskopf,et al. Anemia and perioperative red blood cell transfusion: a matter of tolerance. , 2006, Critical care medicine.
[60] D. Dorr,et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. , 2008, JAMA.
[61] G. Wells,et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.
[62] J. Mcfarland. Perioperative blood transfusions: indications and options. , 1999, Chest.
[63] H. Chaplin. Frozen red cells revisited. , 1984, The New England journal of medicine.
[64] M. Aglietta,et al. The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients , 2006, British Journal of Cancer.
[65] S. Chien,et al. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels , 1987, Transfusion.
[66] P. Hebert,et al. REVIEW OF THE CLINICAL PRACTICE LITERATURE ON ALLOGENEIC RED BLOOD CELL TRANSFUSION , 1997 .
[67] C. Valeri,et al. The volume of blood shed during the bleeding time correlates with the peripheral venous hematocrit. , 1997, American journal of clinical pathology.
[68] Michael J. Bernstein. Perioperative red cell transfusion. , 1988, National Institutes of Health consensus development conference consensus statement.
[69] A. Laupacis,et al. A Meta-analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery , 1999 .
[70] P. Vaupel,et al. Hypoxia and anemia: effects on tumor biology and treatment resistance. , 2005, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
[71] C. Pallister,et al. The impact of anaemia on outcome in cancer. , 2005, Clinical and laboratory haematology.
[72] B. Brozović. Leucocyte depletion of blood and blood components , 1994 .
[73] S. Knowles,et al. Guidelines for compatibility procedures in blood transfusion laboratories , 2004, Transfusion medicine.
[74] T. Prior,et al. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor. , 2000, American journal of clinical pathology.
[75] N. Olivieri. The β-Thalassemias , 1999 .
[76] L. Dahners,et al. Correlation of transfusion volume to change in hematocrit , 2006, American journal of hematology.
[77] D. Prati. Benefits and Complications of Regular Blood Transfusion in Patients with Beta-Thalassaemia major , 2000, Vox Sanguinis.
[78] H. Reesink,et al. Perioperative triggers for red cell transfusions , 2002, Vox sanguinis.
[79] W. Vaughn,et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome , 1999, Transfusion.
[80] G. Escolar,et al. Experimental basis for the use of red cell transfusion in the management of anemic‐thrombocytopenic patients , 1988, Transfusion.
[81] H. Clark,et al. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta‐analysis of unconfounded studies , 1998, The British journal of surgery.
[82] Sunil V. Rao,et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.
[83] M. Eugster,et al. The influence of the haematocrit on primary haemostasis in vitro , 2005, Thrombosis and Haemostasis.
[84] K. Ohene‐Frempong. Indications for red cell transfusion in sickle cell disease. , 2001, Seminars in hematology.
[85] Y. Huang. Monitoring oxygen delivery in the critically ill. , 2005, Chest.
[86] D. Fergusson,et al. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. , 2003, Transfusion medicine reviews.
[87] M. Cazzola,et al. A moderate transfusion regimen may reduce iron loading in beta‐ thalassemia major without producing excessive expansion of erythropoiesis , 1997, Transfusion.
[88] L. Williamson,et al. Preoperative blood transfusions for sickle cell disease. , 2001, The Cochrane database of systematic reviews.
[89] N. Arya,et al. The red cell storage lesion and its implication for transfusion. , 1997, Transfusion science.
[90] P. Hebert,et al. Review of physiologic mechanisms in response to anemia , 1997 .
[91] J. Vincent,et al. Anemia and blood transfusion in critically ill patients. , 2002, JAMA.
[92] R. Strauss. Transfusion Approach to Neonatal Anemia , 2000 .
[93] G. Scambia,et al. Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome. , 2006, Gynecologic oncology.
[94] C. Jersild. [Use of leukocyte-depleted blood components]. , 1997, Ugeskrift for laeger.
[95] P. Hamilton,et al. Guidelines on the management of massive blood loss , 2006, British journal of haematology.
[96] D. Durand,et al. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions , 1985, British journal of haematology.
[97] S. Lewis,et al. British Committee for Standards in Haematology , 1969 .